Pyoderma gangrenosum associated with Takayasu's arteritis responding to cyclosporin

British Journal of Dermatology

Volumn 141, Issue 2, 1999, Pages 339-343

  Fearfield, L A ^a   Ross, J R ^a   Farrell, A M ^a   Costello, C ^a   Bunker, C B ^a   Staughton, R C D ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Cyclosporin; Pyoderma gangrenosum; Takayasu's arteritis

Indexed keywords

ACETYLSALICYLIC ACID; CODYDRAMOL; CYCLOSPORIN; IBUPROFEN; IMMUNOGLOBULIN; MINOCYCLINE; PAPAVERINE;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN BIOPSY; TREATMENT OUTCOME;

ADULT; CYCLOSPORINE; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PYODERMA GANGRENOSUM; TAKAYASU'S ARTERITIS; WOUND HEALING;

EID: 0032793247     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02989.x     Document Type: Article

References (31)

1. Hall S, Barr W, Lie JT et al. Takayasu arteritis: a study of 32 North American patients. Medicine 1985; 64: 89-99.
2. Frances C, Boisnic O, Bletry O et al. Cutaneous manifestations of Takayasu arteritis. Dermatologica 1990; 181: 266-72.
3. Perniciaro C, Winkelmann RK, Hunder GG. Cutaneous manifestations of Takayasu's arteritis. J Am Acad Dermatol 1987; 17: 998-1005.
4. Nakao K, Ikeda M, Kimata S-I et al. Takayasu's arteritis. Clinical reports of eighty-four cases and immunological studies of seven cases. Circulation 1967; 35: 1141-55.
5. Lupi-Herrera E, Sanchez-Torres G, Marchushamer J et al. Takayasu's arteritis: clinical study of 107 cases. Am Heart J 1977; 93: 94-103.
6. Dagan O, Barak Y, Metzker A. Pyoderma gangrenosum and sterile multifocal osteomyelitis preceding the appearance of Takayasu arteritis. Pediatr Dermatol 1995: 12: 39-42.
7. Cajigas J-C, Amigo M-C, Pineda C et al. Association between Takayasu's arteritis and cutaneous polyarteritis nodosa. Am J Med 1987; 82: 382-4.
8. Taieb A, Dufillot D, Pellegrin-Carloz B. et al. Postgranulomatous anetoderma associated with Takayasu's arteritis in a child. Arch Dermatol 1987; 123: 796-800.
9. Chaffai M, Hamza M, Bnouni B et al. Pyoderma gangrenosum au cours d'une arterite de Takayasu. Ann Dermatol Venereol 1982; 109: 755-6.
10. Hidano A, Watanabe K. Pyoderma gangrenosum et cardiovasculopathies en particulier arterite de Takayasu. Ann Dermatol Venereol 1981; 108: 13-21.
11. Kerr G. Takayasu's arteritis. Curr Opin Rheumatol 1994; 6: 32-8.
12. Ishikawa K, Mactani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Circulation 1994; 90: 1855-60.
13. Kerr G, Hallahan C. Leavitt R et al. A study of 60 patients with Takayasu's arteritis: presentation, treatment and long-term outcome. Arthritis Rheum 1993; 36 (Suppl.): R5.
14. Saxe PA, Altman RH. Takayasu's arteritis syndrome associated with systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21: 295-305.
15. Falicov RE, Cooney DF. Takayasu's arteritis and rheumatoid arthritis: a case report. Arch Intern Med 1964; 114: 594-600.
16. Misra R, Aggarwal A, Chag M et al. Raised anticardiolipin antibodies in Takayasu's arteritis. Lancet 1994; 343: 1644-5.
17. Weyand CM, Goronzy JJ. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis. Curr Opin Rheumatol 1995; 7: 30-6.
18. Volkman DJ, Mann DL, Fauci AS. Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. N Engl J Med 1982; 306: 464-5.
19. Kasuya K, Hushimoto Y, Numano F. Left ventricular dysfunction and HLA-Bw52 antigen in Takayasu's arteritis. Heart Vessels 1992; 7: 116-9.
20. Shinkai H, Mori Y, Nishioka G. Pyoderma gangrenosum associated with aortitis syndrome. Rinsho Dermatol 1970; 12: 773-85.
21. Powell F, Su D, Perry H. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.
22. Ishikawa K. Natural history and classification of occlusive thrombo-aortopathy (Takayasu's disease). Circulation 1978; 57: 27-35.
23. Kerr GS, Hallahan CW, Giordarno J et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919-29.
24. Sholhamer JH, Volkman DJ, Parillo JE et al. Takayasu's arteritis and its therapy. Ann Intern Med 1985; 103: 121-6.
25. Hoffman G. Treatment of resistant Takayasu's arteritis. Rheum Dis Clin N Am 1995; 21: 73-80.
26. Mevorach D, Leibowitz G, Brezis M, Raz E. Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate. Ann Rheum Dis 1991; 51: 904-5.
27. Curley RK, Macfarlane AW, Vickers CFH. Pyoderma gangrenosum treated with cyclosporin A. Br J Dermatol 1985; 113: 601-4.
28. Elgart G, Stover P, Larson K et al. Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients. J Am Acad Dermatol 1991; 24: 83-6.
29. Ruzicka T. Cyclosporin in less common immune-mediated skin diseases. Br J Dermatol 1996; 135: 40-2.
30. Gupta AK, Shear NH, Sauder DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol 1995; 32: 140-2.
31. Ballow M. Mechanisms of action of intravenous immune globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol 1997; 100: 151-7.